Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment
Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke
worldwide and confers one of the greatest risks of recurrent stroke compared with other …
worldwide and confers one of the greatest risks of recurrent stroke compared with other …
Neuroprotective effect of SGLT2 inhibitors
A Pawlos, M Broncel, E Woźniak, P Gorzelak-Pabiś - Molecules, 2021 - mdpi.com
Patients with diabetes are at higher risk of cardiovascular diseases and cognitive
impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin …
impairment. SGLT2 inhibitors (Empagliflozin, Canagliflozin, Dapagliflozin, Ertugliflozin …
Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of …
BV Zlokovic, RF Gottesman, KE Bernstein… - Alzheimer's & …, 2020 - Wiley Online Library
Vascular contributions to cognitive impairment and dementia (VCID) are characterized by
the aging neurovascular unit being confronted with and failing to cope with biological insults …
the aging neurovascular unit being confronted with and failing to cope with biological insults …
[HTML][HTML] Emerging concepts in vascular dementia: a review
SC Bir, MW Khan, V Javalkar, EG Toledo… - Journal of Stroke and …, 2021 - Elsevier
Abstract Objective Vascular dementia (VaD) is the second most common cause of dementia
and a major health concern worldwide. A comprehensive review on VaD is warranted for …
and a major health concern worldwide. A comprehensive review on VaD is warranted for …
Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?
K Govindpani, LG McNamara, NR Smith… - Journal of clinical …, 2019 - mdpi.com
Alzheimer's disease (AD) is the most prevalent form of dementia. Despite decades of
research following several theoretical and clinical lines, all existing treatments for the …
research following several theoretical and clinical lines, all existing treatments for the …
European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease
M Psychogios, A Brehm… - European Stroke …, 2022 - journals.sagepub.com
The aim of the present European Stroke Organisation guideline is to provide clinically useful
evidence-based recommendations on the management of patients with intracranial …
evidence-based recommendations on the management of patients with intracranial …
Cerebrovascular alterations in Alzheimer disease: incidental or pathogenic?
C Iadecola, RF Gottesman - Circulation research, 2018 - Am Heart Assoc
Experimental studies suggest that Aβ can reduce cerebral blood flow, induce neurovascular
dysfunction, and increase the susceptibility of the brain to ischemia. 2 Indeed, patients with a …
dysfunction, and increase the susceptibility of the brain to ischemia. 2 Indeed, patients with a …
Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy
Vascular contributions to cognitive impairment and dementia (VCID) are a common cause of
cognitive decline, yet limited therapies exist. This cerebrovascular disease results in …
cognitive decline, yet limited therapies exist. This cerebrovascular disease results in …
Intracranial atherosclerotic disease
Intracranial atherosclerosis (ICAS) is a progressive pathological process that causes
progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence …
progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence …
Vascular cognitive impairment
J Graff-Radford - Continuum: Lifelong Learning in Neurology, 2019 - journals.lww.com
Vascular Cognitive Impairment : CONTINUUM: Lifelong Learning in Neurology Account
Register Activate Subscription Help Subscribe American Academy of Neurology Login Journal …
Register Activate Subscription Help Subscribe American Academy of Neurology Login Journal …